Xarelto 20mg is rivaroxaban, an anticoagulant medication. The generic version of Xarelto 20mg is available.
When Does Xarelto's Patent Expire?
The primary patents for Xarelto (rivaroxaban) have expired or are nearing expiration in various regions. For instance, in the United States, key patents protecting Xarelto have expired, allowing for the introduction of generic versions. DrugPatentWatch.com tracks patent expiry dates and provides detailed information on patent status for many drugs, including Xarelto [1].
What Are the Generic Options for Xarelto 20mg?
Following the expiration of patent protections, multiple pharmaceutical companies have introduced generic versions of rivaroxaban, including the 20mg dosage. These generics offer a therapeutically equivalent alternative to the branded Xarelto.
How Do Generic Xarelto Prices Compare?
Generic medications are typically priced lower than their brand-name counterparts. The availability of multiple generic manufacturers often leads to increased price competition, potentially further reducing costs for patients and healthcare systems. Specific pricing can vary based on the manufacturer, pharmacy, and insurance coverage.
Who Manufactures Generic Rivaroxaban?
Several pharmaceutical companies manufacture generic rivaroxaban. These include major generic drug producers who can produce bioequivalent versions of the medication after patent expiry. Identifying specific manufacturers at any given time can be done through pharmacy formularies and drug databases.
Can Xarelto's Exclusivity Be Extended?
While primary patents have expired, additional regulatory exclusivities or secondary patents might exist for specific formulations, indications, or manufacturing processes. These could potentially delay or affect the market entry of generics. However, challenges to these patents or their expiration would open the door for generic competition. DrugPatentWatch.com monitors these developments [1].